Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 · Cancer Cell · 145 citations
https://doi.org/10.1016/j.ccell.2018.08.003
A
Andrew Mancini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
1.2K
Citations
8
h-index
8
i10-index
Andrew Mancini is an academic researcher from Molecular Oncology (United States). The author has contributed to research in topics: Telomeres, Telomerase, and Senescence & Glioma Diagnosis and Treatment & Cancer Research and Treatments. The author has an h-index of 8, co-authored 20 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat